Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- BLFS
- Price
- 21.22
- Stock movement up
- +0.12 (0.48%)
- Company name
- BioLife Solutions Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 1.20B
- Ent value
- 1.23B
- Price/Sales
- 9.74
- Price/Book
- 3.69
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- 170.03
- PEG
- -
- EPS growth
- -
- 1 year return
- -5.07%
- 3 year return
- -0.36%
- 5 year return
- 6.25%
- 10 year return
- 28.39%
Last updated: 2025-09-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
BLFS does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | 132.07 |
| Price to FCF | 212.61 |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 9.74 |
| Price to Book | 3.69 |
| EV to Sales | 10.00 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 47.91M |
| EPS (TTM) | -1.00 |
| FCF per share (TTM) | 0.12 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 123.36M |
| Gross profit (TTM) | 56.68M |
| Operating income (TTM) | -27.82M |
| Net income (TTM) | -46.03M |
| EPS (TTM) | -1.00 |
| EPS (1y forward) | 0.15 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 45.95% |
| Operating margin (TTM) | -22.55% |
| Profit margin (TTM) | -37.31% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 23.98M |
| Net receivables | 17.92M |
| Total current assets | 89.38M |
| Goodwill | 224.74M |
| Intangible assets | 18.41M |
| Property, plant and equipment | 0.00 |
| Total assets | 381.65M |
| Accounts payable | 3.84M |
| Short/Current long term debt | 39.27M |
| Total current liabilities | 32.17M |
| Total liabilities | 56.19M |
| Shareholder's equity | 325.46M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 9.10M |
| Capital expenditures (TTM) | 3.45M |
| Free cash flow (TTM) | 5.65M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -14.14% |
| Return on Assets | -12.06% |
| Return on Invested Capital | -13.51% |
| Cash Return on Invested Capital | 1.66% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 24.73 |
| Daily high | 25.30 |
| Daily low | 24.45 |
| Daily Volume | 401K |
| All-time high | 1373.75 |
| 1y analyst estimate | 31.30 |
| Beta | 1.76 |
| EPS (TTM) | -1.00 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 6 Nov 2025 |
Downside potential
Loading...
Downside potential data
| BLFS | S&P500 | |
| Current price drop from All-time high | -98.17% | -1.46% |
| Highest price drop | -99.98% | -56.47% |
| Date of highest drop | 12 Oct 2011 | 9 Mar 2009 |
| Avg drop from high | -90.71% | -10.99% |
| Avg time to new high | 241 days | 12 days |
| Max time to new high | 7980 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
1.20B
Marketcap category
Small-cap
Description
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Employees
159
Investor relations
-
SEC filings
CEO
Michael P. Rice
Country
USA
City
Bothell
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page